| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.096 | 0.6 |